Literature DB >> 16351582

Long term protection after hepatitis B vaccination.

Sandra Puvacić1, Jelena Ravlija, Zlatko Puvacić, Ivan Curić.   

Abstract

A survey of persistence of anti-HBs after hepatitis B vaccination has shown that five years after vaccination on a sample of 152 persons, or 82.53%, stands at >10 IU/I. Long term immunogenicity of vaccinated children remained at 88.89%, health workers 79.41% and drug addicts 64.28%. The results of these studies in Bosnia and Herzegovina show the high level of protection hepatitis B vaccine against HBV infection. Vaccination against viral hepatitis B results in immunologic memory response among the vaccinated, and even after a decrease of anti-HB level following the third vaccine dose inoculation, a booster dose is not needed. Immunity remains steady and a booster dose is not recommended.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16351582      PMCID： PMC7202160     

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN： 1512-8601            Impact factor:   3.363


  17 in total

Review 1.  Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

Authors:  G François; M Kew; P Van Damme; M J Mphahlele; A Meheus
Journal:  Vaccine       Date:  2001-07-16       Impact factor: 3.641

Review 2.  Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

Authors: 
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

3.  Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus.

Authors:  Toru Shizuma; Kiyoshi Hasegawa; Kayo Ishikawa; Takuma Naritomi; Aiko Iizuka; Naoko Kanai; Miho Ogawa; Nobuyuki Torii; Riho Joh; Naoaki Hayashi
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

4.  Persistence of specific antibodies after hepatitis B vaccination.

Authors:  W Jilg; M Schmidt; F Deinhardt
Journal:  J Hepatol       Date:  1988-04       Impact factor: 25.083

5.  Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

Authors:  M Gesemann; N Scheiermann
Journal:  Vaccine       Date:  1995-04       Impact factor: 3.641

Review 6.  Biology of hepatitis B virus variants.

Authors:  M A Feitelson
Journal:  Lab Invest       Date:  1994-09       Impact factor: 5.662

Review 7.  Viral genetic variation: hepatitis B virus as a clinical example.

Authors:  W Carman; H Thomas; E Domingo
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

8.  Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B.

Authors:  F Z al-Faleh; E A Ayoola; M Arif; S Ramia; R al-Rashed; M al-Jeffry; M al-Mofarreh; M al-Karawi; M al-Shabrawy
Journal:  J Infect       Date:  1992-03       Impact factor: 6.072

9.  Current aspects of hepatitis B surface antigen mutants in Singapore.

Authors:  C J Oon; W N Chen
Journal:  J Viral Hepat       Date:  1998-11       Impact factor: 3.728

Review 10.  Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.

Authors:  Alfonso Mele; Tommaso Stroffolini; Alessandro R Zanetti
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327
View more
  2 in total

1.  Management of accidental exposure to HCV, HBV and HIV in healthcare workers in Romania.

Authors:  Eyal Malka; Anca Streinu-Cercel; Daniela Piţigoi; Rodica Bacruban
Journal:  Germs       Date:  2012-12-01

2.  Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study.

Authors:  Sylvester Dassah; Samuel A Sakyi; Margaret T Frempong; Arnold T Luuse; Richard K D Ephraim; Enoch O Anto; Abraham Oduro
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.